Terry W Moody Selected Research

Bombesin

1/2021	Bombesin, endothelin, neurotensin and pituitary adenylate cyclase activating polypeptide cause tyrosine phosphorylation of receptor tyrosine kinases.
11/2019	Peptide receptors as cancer drug targets.
1/2018	Neuropeptide G Protein-Coupled Receptors as Oncotargets.
9/2016	Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment.
1/2016	EGFR Transactivation by Peptide G Protein-Coupled Receptors in Cancer.
10/2015	Neuropeptides as lung cancer growth factors.
1/2011	Bombesin receptor-mediated imaging and cytotoxicity: review and current status.
7/2010	Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.
4/2008	Bombesin marine toxin conjugates inhibit the growth of lung cancer cells.
1/2006	Bombesin/gastrin-releasing peptide receptor antagonists increase the ability of histone deacetylase inhibitors to reduce lung cancer proliferation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Terry W Moody Research Topics

Disease

30	Neoplasms (Cancer) 01/2021 - 10/2002
28	Lung Neoplasms (Lung Cancer) 01/2021 - 04/2002
13	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 04/2002
7	Breast Neoplasms (Breast Cancer) 02/2016 - 10/2002
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 11/2019 - 01/2003
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2019 - 01/2003
4	Carcinogenesis 03/2009 - 05/2002
2	Central Nervous System Diseases (CNS Diseases) 01/2021 - 02/2011
2	Neoplasm Metastasis (Metastasis) 01/2017 - 05/2005
2	Adenocarcinoma 03/2009 - 07/2002
2	Adenoma (Adenomas) 09/2007 - 07/2002
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021
1	Migraine Disorders (Migraine) 01/2021
1	Rheumatoid Arthritis 01/2021
1	Neuroblastoma 02/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Schizophrenia (Dementia Praecox) 02/2011

Drug/Important Bio-Agent (IBA)

13	Peptides (Polypeptides)IBA 08/2021 - 09/2006
12	BombesinIBA 01/2021 - 01/2003
12	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 11/2002
11	Tyrosine (L-Tyrosine)FDA Link 08/2021 - 05/2002
10	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 08/2021 - 11/2002
10	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 01/2021 - 10/2002
10	Bombesin Receptors (Bombesin Receptor)IBA 01/2021 - 08/2003
7	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 08/2021 - 01/2011
7	NeurotensinIBA 01/2021 - 05/2002
7	ErbB Receptors (EGF Receptor)IBA 10/2019 - 07/2010
6	Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)IBA 09/2007 - 10/2002
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 06/2012
5	NeuropeptidesIBA 01/2020 - 01/2003
5	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2019 - 01/2012
4	bombesin receptor subtype 3IBA 01/2018 - 08/2010
4	Cholecystokinin (Pancreozymin)IBA 01/2016 - 12/2006
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
3	Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA 01/2021 - 06/2012
3	Messenger RNA (mRNA)IBA 12/2019 - 01/2004
3	Cytotoxins (Cytolysins)IBA 01/2018 - 09/2006
3	Epidermal Growth Factor (EGF)IBA 01/2017 - 07/2010
3	Gefitinib (Iressa)FDA Link 01/2016 - 06/2012
3	Glucose (Dextrose)FDA LinkGeneric 02/2011 - 10/2002
3	CarcinogensIBA 03/2009 - 07/2002
3	Gastrin-Releasing PeptideIBA 02/2008 - 06/2005
3	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 09/2007 - 05/2004
3	CamptothecinIBA 09/2007 - 05/2004
2	Endothelins (Endothelin)IBA 01/2021 - 01/2017
2	Neurotensin Receptors (Neurotensin Receptor)IBA 12/2019 - 05/2002
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 07/2002
2	Cell Surface ReceptorsIBA 11/2019 - 01/2018
2	Peptide Receptors (Peptide Receptor)IBA 11/2019 - 09/2016
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 03/2018 - 03/2009
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2018 - 09/2005
2	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2016 - 01/2011
2	GastrinsIBA 01/2016 - 07/2015
2	Cholecystokinin Receptors (Cholecystokinin Receptor)IBA 01/2016 - 07/2015
2	Metalloproteases (Metalloproteinases)IBA 07/2015 - 08/2011
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2012 - 05/2002
2	neuromedin BIBA 07/2010 - 02/2008
2	2- ((2,6- dichlorophenyl)amino)benzeneacetic acid 4-(3H-1,2-dithiol-3-thione-5-yl)phenyl esterIBA 05/2010 - 03/2009
2	S-sulindacIBA 05/2010 - 03/2009
2	ThymalfasinIBA 09/2007 - 05/2002
2	Urethane (Ethyl Carbamate)IBA 09/2007 - 07/2002
2	AntigensIBA 09/2007 - 01/2004
2	Peptide Hormones (Polypeptide Hormones)IBA 09/2006 - 08/2004
2	BromidesIBA 09/2006 - 05/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2006 - 07/2002
2	PD 176252IBA 01/2006 - 08/2003
2	Type I Vasoactive Intestinal Polypeptide ReceptorsIBA 12/2004 - 01/2004
2	(VIP-neurotensin) hybrid antagonistIBA 01/2004 - 01/2003
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2003 - 11/2002
1	NeuregulinsIBA 08/2021
1	Therapeutic UsesIBA 01/2021
1	Amino Acids FDA Link 12/2019
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2019
1	Phosphotransferases (Kinase)IBA 10/2019
1	AntioxidantsIBA 03/2018
1	Retinaldehyde (Retinal)IBA 03/2018
1	nitroxylIBA 03/2018
1	Growth Factor ReceptorsIBA 01/2018
1	Octreotide (Sandostatin)FDA LinkGeneric 01/2018
1	CalciumIBA 01/2018
1	Type C PhospholipasesIBA 01/2018
1	Cholecystokinin B ReceptorIBA 01/2016
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2016
1	AntibodiesIBA 01/2016
1	N- (2(R)- 2- (hydroxamidocarbonylmethyl)- 4- methylpentanoyl)- L- tryptophan methylamideIBA 07/2015
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2015
1	Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA 07/2015
1	PD 134308IBA 07/2015
1	gastrin 17 (G 17)IBA 07/2015
1	Sincalide FDA Link 07/2015
1	Superoxides (Superoxide)IBA 07/2015
1	1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium SaltIBA 07/2015
1	SR 48692IBA 03/2014
1	PaxillinIBA 01/2012
1	Oxygen (Dioxygen)IBA 08/2011
1	Neuroprotective AgentsIBA 02/2011
1	Cadherins (E-Cadherin)IBA 05/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 05/2010

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2005
2	Lasers (Laser) 01/2004 - 07/2002